featured
Highlights of the Year in JACC 2013
Sign in to PracticeUpdate
Only registered members have full access to PracticeUpdate content.
Additional Info
- PARTNER Outcomes Hold Firm Over Time
- Advances in Aortic Valve Disease
- Multicenter Core Laboratory Comparison of the Instantaneous Wave-Free Ratio andResting Pd/Pa With Fractional Flow Reserve: The RESOLVE Study
- Rivaroxaban 2.5mg Shows Strong Mortality Benefit Following STEMI
- The Impact of Residual Coronary Lesions on Clinical Outcomes After Percutaneous Coronary Intervention: Residual SYNTAX Score After PCI in Patients From the EXCELLENT Registry
- DK Crush Edges Culotte for Left Main PCI
- ATLAS: Addition of Rivaroxaban Reduces Stent Thrombosis After ACS
- Past, Present, and Future of Drug-Eluting Stents
- Percutaneous Interventions in the Management of Structural Heart Disease—Part I
- LAV Is Predictive for Benefit From CRT for Mild Heart Failure
- Heart Failure With Preserved Ejection Fraction: Part 1
- 2013 Top Stories in Cardiology: Heart Failure and Transplantation
- Gaining Success in Heart Failure
- Rhythm vs Rate Control in Atrial Fibrillation
- MY APPROACH to Selection of Atrial Fibrillation Patients for Ablation
Journal of the American College of Cardiology